Medical Device | Healthcare | Biotechnology | Pharmaceuticals

  Oligonucleotide synthesis market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques. This study involved four major activities to estimate the current size of the oligonucleotide synthesis market . Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Market Size Estimation: Both top-down and bottom-up approaches were used to estimate and validate the total size of the oligonucleotide synthesis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate ...

  Oligonucleotide Synthesis market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques. Oligonucleotide Synthesis Market Dynamics: Impact Analysis 1. Attractive Opportunities in the Market 2. Increasing Use of Synthesized Oligos in Molecular Diagnostics 3. Clinical Applications 4. R&D Expenditure in Pharmaceutical and Biotechnology Companies The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7% Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Oligonucleotide Synthesis market? 2. What are the drivers, restraints, opportunities, and challenges in the Oligonucleotide Synthesis Industry? 3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players? 4. What...

Oligonucleotide Synthesis market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques. Oligonucleotide Synthesis Market Dynamics: Impact Analysis 1. Attractive Opportunities in the Market 2. Increasing Use of Synthesized Oligos in Molecular Diagnostics 3. Clinical Applications 4. R&D Expenditure in Pharmaceutical and Biotechnology Companies The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7% Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Oligonucleotide Synthesis market? 2. What are the drivers, restraints, opportunities, and challenges in the Oligonucleotide Synthesis Industry? 3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players? 4. What will ...

Oligonucleotide synthesis market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques. What the Market Looks Like? The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7%. Therapeutic Application: The therapeutic applications segment, which is further segmented into RNAi oligonucleotide-based therapies, DNA & antisense oligonucleotide-based therapies, and CpG oligonucleotide-based therapies, is estimated to witness the highest growth during the forecast period. This can primarily be attributed to the investments made by companies to explore the therapeutic applications of oligos. Also, from 2016 to 2018, more than five oligonucleotide-based therapies were approved by the FDA. In 2018, these oligonucleotide-based drugs generated a revenue of ~USD 2 billion. Apa...

The oligonucleotide synthesis market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques. What the market looks like? The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7%. The synthesized oligos market, by product, is segmented into oligonucleotide-based drugs, primers, probes, large-scale synthesized oligos, intermediate-scale synthesized oligos, and linkers and adaptors. Of these, oligonucleotide-based accounted for over 50% of the synthesized oligos market share in 2018. This segment is also estimated to grow at the highest CAGR during the forecast period due to the increasing demand for oligonucleotide-based drugs and the influx of new customers in the oligo drug development arena. Apart from this, there are a few oligonucleotide-based drugs in Phase II...